Liposolubility and protein binding of oxycodone in vitro.
about
Oxycodone controlled release in cancer pain managementAnalgesic efficacy, adverse effects, and safety of oxycodone administered as continuous intravenous infusion in patients after total hip arthroplasty.Cancer pain management in children.Metabolism of oxycodone in human hepatocytes from different age groups and prediction of hepatic plasma clearance.Pharmacokinetics and tolerability of different doses of fentanyl following sublingual administration of a rapidly dissolving tablet to cancer patients: a new approach to treatment of incident pain.Review of oral oxymorphone in the management of pain.Oxycodone for the treatment of postoperative pain.In vivo profiling of seven common opioids for antinociception, constipation and respiratory depression: no two opioids have the same profile.The disposition of morphine and its 3- and 6-glucuronide metabolites in humans and animals, and the importance of the metabolites to the pharmacological effects of morphine.Prescription opioids. III. Disposition of oxycodone in oral fluid and blood following controlled single-dose administration.Morphine in children with cancer: impact of age, chemotherapy and other factors on protein binding.
P2860
Q24683073-7CB2F6F0-272F-4104-BCFD-0A8430D9FB35Q33650528-F45E0E71-FC01-4A4D-AEE1-D525CC70EAF8Q34499386-3AEC415C-BC3A-440A-B823-52A844A9AC7AQ35653564-6EE80B25-D4A9-4628-A152-5965FC238723Q35826726-19CD699B-084D-44BD-B34B-7B03052E1DB8Q37052760-6121BBBB-B0A5-449A-AF59-6ECBA168214FQ38004077-F487AE07-C455-47AE-9884-5A7E2EC46932Q39209988-EA1B97DA-2E83-446C-A7E1-4F06014DE607Q41170052-B2184A0A-3A94-4D0B-8E75-9406782D3D8FQ41581475-8B5D6C01-695F-40B5-95ED-82012DBB861AQ46886726-55D1C110-BC77-45B8-8461-A600132C57D5
P2860
Liposolubility and protein binding of oxycodone in vitro.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh-hant
name
Liposolubility and protein binding of oxycodone in vitro.
@en
Liposolubility and protein binding of oxycodone in vitro.
@nl
type
label
Liposolubility and protein binding of oxycodone in vitro.
@en
Liposolubility and protein binding of oxycodone in vitro.
@nl
prefLabel
Liposolubility and protein binding of oxycodone in vitro.
@en
Liposolubility and protein binding of oxycodone in vitro.
@nl
P2860
P1476
Liposolubility and protein binding of oxycodone in vitro.
@en
P2093
P2860
P356
10.1111/J.1600-0773.1994.TB01068.X
P577
1994-01-01T00:00:00Z